Showing results (1-10 of 468) with videos related to
Sort By:
Pageof 47
Nanomaterials (Basel, Switzerland)|March 29, 2017
Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer TherapyMathangi Srinivasan, Mehdi Rajabi, Shaker A MousaCurrent Pharmaceutical Biotechnology|April 19, 2016
Lipid Nanoparticles and their Application in NanomedicineMehdi Rajabi, Shaker A MousaCancers|May 25, 2024
RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780Kavitha Godugu, Mehdi Rajabi, Shaker A MousaCancers|November 11, 2022
Correction: Godugu et al. Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780Kavitha Godugu, Mehdi Rajabi, Shaker A MousaCurrent Medicinal Chemistry|June 29, 2019
Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in CancerMehdi Rajabi, Mary Adeyeye, Shaker A MousaCancers|July 2, 2021
Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in GlioblastomaKavitha Godugu, Mehdi Rajabi, Shaker A MousaBioorganic & Medicinal Chemistry Letters|March 10, 2018
Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancerMehdi Rajabi, Murat Yalcin, Shaker A MousaJournal of Medicinal Chemistry|June 24, 2020
Dual Targeting of Norepinephrine Transporter (NET) Function and Thyrointegrin αvβ3 Receptors in the Treatment of NeuroblastomaOzlem Ozen Karakus, Kavitha Godugu, Mehdi Rajabi, et al.Biomedicines|May 19, 2019
Evaluation of Angiogenesis AssaysZachary I Stryker, Mehdi Rajabi, Paul J Davis, et al.Pageof 47